SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Derivatives
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (112)4/20/1999 12:02:00 PM
From: scaram(o)uche  Read Replies (2) of 555
 
I don't know. McCormick is still claiming that defective p53 signal is required for replication. If he's correct, no, it wouldn't change the relationship. Just dents company's rep for accuracy, IMO. The fashion in which it was communicated won't command a ton of respect in the scientific community.

The company's posture might be that nothing has changed, and that, given McCormick's latest rationale, the market just expanded. Until any biological effects are refuted, this is moot.

BTW.... abstracts pointing to this were posted in the relevant thread prior to the meeting.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News